Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia 17Neoplasms 11Leukemia 4Leukemia, Lymphocytic, Chronic, B-Cell 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Multiple Myeloma 2Monoclonal Gammopathy of Undetermined Significance 2Lymphoproliferative Disorders 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Prolymphocytic 2Leukemia, Large Granular Lymphocytic 2Leukemia, Hairy Cell 2Immunoglobulin Light-chain Amyloidosis 2Immunoblastic Lymphadenopathy 2

Interventions

Modafinil 9Methylphenidate 4Saline Solution 3regorafenib 2Sugars 2Physical Therapy Modalities 2Exercise 2Dexamethasone 2reparixin 1ofatumumab 1epoetin beta 1eicosapentaenoic acid ethyl ester 1eicosapentaenoic acid ethanolamide 1clazakizumab 1caffeine, sodium benzoate drug combination 1Yoga 1Walking 1Waiting Lists 1Vinorelbine 1Urinalysis 1Therapeutics 1Thalidomide 1Testosterone 1Sodium Chloride 1Proton Pump Inhibitors 1Patient Reported Outcome Measures 1Megestrol Acetate 1Lenalidomide 1Lactose 1Infliximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fatigue × Epoetin Alfa × Clear all
NCT00004914 2012-06-06

Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue

Northwestern University

Phase 2 Completed
Classical hematology

Anemia, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡